CLINICAL_TRIALS
trial_result
· 2025-03-24
Clinical Trial Update: Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) [Phase 2]
Summary
Phase 2 study of daxdilimab (HZN-7734) in active proliferative lupus nephritis was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2025-03-24